Perthsnooper. Not too many BioTech companies manage to satisy the market optimists. One BioTech company whose story I know fairly well is about one year behind from the "markets forecast of what should happen". The directors have also toned down their forecasts, but things are going EXACTLY to plan (taking out the timeframe) and are looking very good. Very difficult to forecast anything. SBP has a good website and is keeping the market informed. Investors have to figure out whether this is good company or not. Patience is required. At current levels, should their objectives be met, this is a good stock to hold.
